ArticleJournal of cancer research and clinical oncology2019

Combined loss of TFF3 and PTEN is associated with lethal outcome and overall survival in men with prostate cancer.

Hatem Abou-Ouf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.